Haleon plc HLN

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $9.71
Market Cap $43.16B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-1.8% YoY
$11.03B
3-Yr CAGR: 0.5%
Net Income ↓-60.6% YoY
$13.00M
Net Margin: 0.1%
Free Cash Flow ↓-65.9% YoY
$117.00M
FCF Yield: 0.27%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
2.6%
ROA: 0.0%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (HLN)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2020 $9,892.0M $5,910.0M $36.0M $-554.0M $-776.0M
FY 2021 $9,545.0M -3.5% $5,950.0M $49.0M +36.1% $310.0M $82.0M +110.6%
FY 2022 $10,858.0M +13.8% $6,577.0M $59.0M +20.4% $324.0M $20.0M -75.6%
FY 2023 $11,302.0M +4.1% $6,747.0M $62.0M +5.1% $445.0M $211.0M +955.0%
FY 2024 $11,233.0M -0.6% $6,824.0M $33.0M -46.8% $593.0M $343.0M +62.6%
FY 2025 $11,030.0M -1.8% $7,080.0M $13.0M -60.6% $439.0M $117.0M -65.9%
$

Valuation

Market Price $9.71
Market Cap $43.16B
Enterprise Value $42.89B
P/E Ratio N/A
P/B Ratio 85.46
FCF Yield 0.27%
Dividend Yield N/A
Shares Outstanding 4,403,863,692
%

Profitability & Margins

Gross Margin 64.19%
Operating Margin 21.87%
Net Margin 0.12%
Return on Equity (ROE) 2.60%
Return on Assets (ROA) 0.04%
Asset Turnover 0.34x
Revenue 3-Yr CAGR 0.53%
🛡️

Financial Health & Liquidity

Current Ratio 0.24
Cash Ratio 4.96
Debt / Equity 2.113
Debt / Assets 0.032
Cash & Equivalents $1.32B
Total Debt $1.06B
Book Value / Share $0.11
💧

Cash Flow Efficiency

Operating Cash Flow $439.00M
Capital Expenditures (CapEx) $322.00M
Free Cash Flow $117.00M
OCF / Revenue 3.98%
FCF / Revenue 1.06%
FCF 3-Yr CAGR 80.18%
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $0.11
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $32.63B
Total Liabilities $16.15B
Stockholders' Equity $500.10M
Current Assets $65.00M
Current Liabilities $267.00M